Janku Filip
SEC insider (Form 3/4/5 filer). CIK 0001862930. Chief Medical Officer at Monte Rosa Therapeutics, Inc. (GLUE). 11 reported Form 4/5 transactions since Sep 2024; latest on Jun 30, 2026. Located in BOSTON, MA.
Companies Janku Filip has filed insider reports for
- Monte Rosa Therapeutics, Inc. (GLUE): Officer, Chief Medical Officer
Janku Filip
CIK: 0001862930
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Monte Rosa Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Jun 30, 2026GLUE
Monte Rosa Therapeutics, Inc.
SaleDirect5.4K shares at avg. $24.50$132K - Jun 30, 2026GLUE
Monte Rosa Therapeutics, Inc.
ExerciseDirect5.4K shares at avg. $13.41$73K - Jun 24, 2026GLUE
Monte Rosa Therapeutics, Inc.
ExerciseDirect30K shares at avg. $7.56$227K - Jun 24, 2026GLUE
Monte Rosa Therapeutics, Inc.
SaleDirect30K shares at avg. $21.42$643K - Jun 23, 2026GLUE
Monte Rosa Therapeutics, Inc.
ExerciseDirect6K shares at avg. $7.56$45K - Jun 23, 2026GLUE
Monte Rosa Therapeutics, Inc.
SaleDirect11.8K shares at avg. $20.22$240K - Feb 23, 2026GLUE
Monte Rosa Therapeutics, Inc.
SaleDirect9.2K shares at avg. $19.50$179K - Jan 5, 2026GLUE
Monte Rosa Therapeutics, Inc.
SaleDirect3.2K shares at avg. $15.17$48K - Jan 2, 2026GLUE
Monte Rosa Therapeutics, Inc.
AwardDirect31K shares- - Jan 2, 2025GLUE
Monte Rosa Therapeutics, Inc.
AwardDirect36K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 30, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Sale | 5,407 | $24.50 | $132,472 | Direct |
| Jun 30, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Exercise | 5,407 | $13.41 | $72,508 | Direct |
| Jun 24, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Exercise | 30,000 | $7.56 | $226,800 | Direct |
| Jun 24, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Sale | 30,000 | $21.42 | $642,681 | Direct |
| Jun 23, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Exercise | 6,000 | $7.56 | $45,360 | Direct |
| Jun 23, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Sale | 11,845 | $20.22 | $239,522 | Direct |
| Feb 23, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Sale | 9,189 | $19.50 | $179,161 | Direct |
| Jan 5, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Sale | 3,155 | $15.17 | $47,861 | Direct |
| Jan 2, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Award | 31,000 | - | $0 | Direct |
| Jan 2, 2025 | GLUE Monte Rosa Therapeutics, Inc. | Award | 36,000 | - | $0 | Direct |
1-10 of 11 transactions